South and Central America Protein Expression Market Segments and Growth by 2028
South and Central America Protein Expression Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Competent Cells, Expression Vectors, Reagents, and Instruments); Services (Antibody Development & Production, Protein Expression & Production, Hybridoma One-Stop Services, Stable Cell Line Development, and Bioanalytical Assay Services); Application (Research, Therapeutic, and Industrial); End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, and Others)
- Status : Published
- Report Code : TIPRE00025109
- Category : Life Sciences
- No. of Pages : 141
- Available Report Formats :
- Last update date : October 05, 2021
2021 Market Size
US$ 91.5 Mn
Base year value
2028 Forecast
US$ 158.8 Mn
Projected by 2028
CAGR 2022-2028
8.2 %
Growth rate
Addressable Market
US$ 888.81 Mn
(2022-2028)
The protein expression market in South and Central America is expected to grow from US$ 91.5 million in 2021 to US$ 158.8 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.
The rising incidence of chronic diseases and increasing advancements in the biopharmaceutical industry are projected to drive the demand for protein expression techniques in the coming years. In addition, advancements in bioprocessing technologies have favoured the adoption of protein expression, which has further increased the use of recombinant proteins in therapeutics. According to a white paper article, “Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing,” published in 2019, over 170 recombinant proteins are used for therapeutic purposes across the world, and the number of such recombinant proteins is expected to rise in the future. The production of recombinant protein is a complex, multidisciplinary, and expensive process, and hence it is not yet widely adopted. However, growing awareness has increased the demand for these proteins for human therapeutics. Also, the ongoing developments and evolving healthcare sector are expected to bring advancements in the process of producing recombinant proteins at affordable prices. Furthermore, commercial players seek opportunities to adopt easier, simpler, and automated methods for product development. Therefore, they are continuously striving to develop therapeutic products through economic processes to serve a large population.
COVID-19 pandemic has become the most significant challenge in the region. However, demand for protein expression systems in this pandemic is inclined from the outbreak of Covid-19, but now the pharma companies are working on developing strategies to develop and manufacture the required reagents, instruments for the research of vaccine fulfill the demands of protein expression. The demand of protein expression in the region is expected to increase due to the rising Covid-19 cases and other diseases such as cancer. Similarly, Latin America is hit by the COVID-19 pandemic and thus has profound humanitarian, economic, and political consequences. South and Central America are among the regions with rising number of reported cases of COVID-19. They have responded to the situation by closing borders, ordering quarantines, and imposing a host of restrictions to keep people confined at home. The impact of the COVID19 pandemic on the regional protein expression market is moderate.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the protein expression market. The South and Central America protein expression market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
South and Central America Protein Expression Market Segmentation
By Product
- Competent Cells
- Expression Vectors
- Reagents
- Instruments
By Services
- Antibody Development & Production
- Protein Expression & Production
- Hybridoma One-Stop Services
- Stable Cell Line Development
- Bioanalytical Assay Services
By Application
- Research
- Therapeutic
- Industrial
By End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic Research Institutes
- Others
By Country
-
South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Companies Mentioned
- Thermo Fisher Scientific Inc.
- GenScript
- Merck KGaA
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN
- New England Biolabs
- Promega Corporation
South and Central America Protein Expression Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 91.5 Million |
| Market Size by 2028 | US$ 158.8 Million |
| CAGR (2021 - 2028) | 8.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners provided valuable market intelligence that supported our global go-to-market strategy. Their team was professional, responsive, and attentive to our feedback, providing thoughtful analysis and helpful methodological clarifications throughout the project.
Junmo Kim Chief Financial Officer (CFO), Enertech Co., Ltd.
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for